Evaxion's stock soars after getting FDA approval for mid-stage cancer trial

U.S.-listed shares of Evaxion Biotech A/S jumped about 17% in premarket trading on Tuesday after the company said the Food and Drug Administration has allowed a Phase 2b clinical trial testing its experimental cancer vaccine to move forward. The study is evaluating Evaxion's EVX-01 in combination with Merck & Co. Inc.'s Keytruda as a treatment for metastatic melanoma in Australia, Europe, and the U.S.

-listed shares of Evaxion Biotech A/S EVAX jumped about 17% in premarket trading on Tuesday after the company said the Food and Drug Administration has allowed a Phase 2b clinical trial testing its experimental cancer vaccine to move forward. The study is evaluating Evaxion's EVX-01 in combination with Merck & Co. Inc.'s MRK Keytruda as a treatment for metastatic melanoma in Australia, Europe, and the U.S.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA decision on experimental Alzheimer's drug expected this week | CNNThe US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental Alzheimer's drug lecanemab, according to Eisai and Biogen, the companies that make the drug. MehdiMohammadiFard , 18 y/o, was arrested by the security forces of the IR regime in Noshahr, Iran. He has been sentenced to death twice, on charges of 'Corruption on Earth' and 'Moharabe: waging a war against God..Please be his voice MahsaAmini No one trusts the FDA
Source: CNN - 🏆 4. / 95 Read more »